U.S. federal trademark · Serial No. 75573895
Pharmaceuticals, namely, monoclonal antibodies and fragments thereof for clinical, diagnostic and therapeutic use for the treatment of cancer, autoimmune diseases, infectious diseases, inflammatory diseases and genetic diseases
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.